Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics
- PMID: 39781566
- PMCID: PMC11709447
- DOI: 10.1007/s10404-024-02741-z
Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics
Abstract
The blood-brain barrier (BBB) protects the brain by actively allowing the entry of ions and nutrients while limiting the passage of from toxins and pathogens. A healthy BBB has low permeability and high selectivity to maintain normal brain functions. Increased BBB permeability can result from neurological diseases and traumatic injuries. Modern engineering technologies such as microfluidics and fabrication techniques have advanced the development of BBB models to simulate the basic functions of BBB. However, the intrinsic BBB properties are difficult to replicate. Existing in vitro BBB models demonstrate inconsistent BBB permeability and selectivity due to variations in microfluidic design, cell types and arrangement, expression of tight junction (TJ) proteins, and use of shear stress. Specifically, microfluidic designs have flow channels of different sizes, complexity, topology, and modular structure. Different cell types are selected to mimic various physiological conditions. These factors make it challenging to compare results obtained using different experimental setups. This paper highlights key factors that play important roles in influencing microfluidic models and discusses how these factors contribute to permeability and selectivity of the BBB models.
Keywords: Blood-brain barrier; Cells; Design; Microfluidics; Permeability; Selectivity.
Conflict of interest statement
Conflict of interest The authors declare no conflict of interest.
Figures



Similar articles
-
Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.Biotechnol Bioeng. 2017 Jan;114(1):184-194. doi: 10.1002/bit.26045. Epub 2016 Jul 21. Biotechnol Bioeng. 2017. PMID: 27399645 Free PMC article.
-
Recent Progress in Microfluidic Models of the Blood-Brain Barrier.Micromachines (Basel). 2019 Jun 5;10(6):375. doi: 10.3390/mi10060375. Micromachines (Basel). 2019. PMID: 31195652 Free PMC article. Review.
-
Matrix stiffness regulates the tight junction phenotypes and local barrier properties in tricellular regions in an iPSC-derived BBB model.Acta Biomater. 2023 Sep 1;167:109-120. doi: 10.1016/j.actbio.2023.06.003. Epub 2023 Jun 10. Acta Biomater. 2023. PMID: 37302732
-
Real-time monitoring of a 3D blood-brain barrier model maturation and integrity with a sensorized microfluidic device.Lab Chip. 2024 Nov 5;24(22):5085-5100. doi: 10.1039/d4lc00633j. Lab Chip. 2024. PMID: 39412878 Free PMC article.
-
Recent advances in blood-brain barrier-on-a-chip models.Acta Biomater. 2025 May 1;197:1-28. doi: 10.1016/j.actbio.2025.03.041. Epub 2025 Mar 22. Acta Biomater. 2025. PMID: 40127880 Review.
Cited by
-
Cost-effective isolation of Viburnum opulus-derived nanovesicles and evaluation of their cytotoxic, anticancer, and antioxidant properties on human glioblastoma cell line U87MG.Med Oncol. 2025 Mar 17;42(4):112. doi: 10.1007/s12032-025-02669-6. Med Oncol. 2025. PMID: 40095218 Free PMC article.
References
-
- Abbott NJ (2013) Blood–brain barrier structure and function and the challenges for cns drug delivery. J Inherit Metab Dis 36(3):437–449 - PubMed
-
- Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7(1):41–53 - PubMed
-
- Aday S, Cecchelli R, Hallier-Vanuxeem D, Dehouck M, Ferreira L (2016) Stem cell-based human blood-brain barrier models for drug discovery and delivery. Trends Biotechnol 34(5):382–393 - PubMed
-
- Adriani G, Ma D, Pavesi A, Kamm RD, Goh EL (2017) A 3d neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood–brain barrier. Lab Chip 17(3):448–459 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources